Chemical Toxic Injury

Slide 1 · Chemical (Toxic) Injury

Mechanisms of cell injury and clinicopathologic examples

Pathology lecture

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Distinguish direct toxicity from toxic-metabolite formation.

Explain cytochrome P450, phase I/II reactions, and oxidative injury.

Trace injury mechanisms for mercury, cyanide, CCl₄, and acetaminophen.

Connect molecular damage with organ selectivity and cell death.

Slide 3 · Why chemical injury matters clinically

Chemical injury is a frequent cause of cellular damage.

Drug toxicity is an important limitation to treatment and development.

The liver is particularly exposed because it metabolizes many drugs.

Different chemicals converge on a small set of cellular targets.

Slide 4 · Environmental exposure reaches target cells

External chemical

Drug, environmental contaminant or toxin

Entry

Inhalation, ingestion or skin contact

Distribution

Local action or delivery via blood

Target tissue

Injury, storage, metabolism or excretion

The site of entry and the site of maximal injury need not be the same.

Slide 5 · Local versus systemic toxic effects

At the site of entry

Initial contact with skin, lung or gastrointestinal mucosa.

Injury may precede extensive systemic distribution.

Local concentration contributes to severity.

After distribution

Blood delivers xenobiotics to distant organs.

Liver may metabolize circulating compounds.

Kidney may concentrate agents during excretion.

Organ tropism is determined partly by exposure, uptake, concentration, and metabolism.

Slide 6 · Toxicity depends on exposure and the host

Dose is fundamental: A therapeutic substance can become toxic.

Absorption, distribution, metabolism and excretion alter effective exposure.

Age, genetics and tissue susceptibility contribute to variable responses.

Drug and environmental exposures may change metabolic enzyme activity.

Slide 7 · Why one organ is injured more than another

Concentration

≠

Uniform injury

Cells that absorb or concentrate a toxin receive greater exposure.

A tissue may activate a relatively inert chemical.

Cell-specific defenses modify susceptibility.

Examples: Gastrointestinal tract and kidney with mercuric chloride; Liver with many drugs.

Slide 8 · Two major mechanisms of chemical injury

Direct toxicity

Parent compound is itself injurious.

Direct interaction with critical cell molecules.

Examples: Mercury and cyanide.

Metabolic activation

Parent compound is converted to a reactive product.

Reactive metabolites attack lipids and proteins.

Examples: CCl₄ and acetaminophen.

This distinction is mechanistic: Both pathways can culminate in membrane or mitochondrial damage.

Slide 9 · Direct toxicity starts at a molecular target

A chemical binds to, inhibits, or otherwise disrupts a critical molecule.

The immediate molecular lesion determines the first cellular dysfunction.

Damage severity depends on exposure and cellular reliance on that target.

Slide 10 · Mercury directly modifies membrane proteins

Mercuric chloride

Mercury-containing toxicant

Sulfhydryl binding

Interaction with –SH groups of proteins

Membrane dysfunction

Increased permeability; Impaired ion transport

Direct binding to protein functional groups alters membrane physiology.

Slide 11 · Membrane transport failure propagates injury

Protein modification

Functional membrane proteins impaired

Ion movement disturbed

Transport and permeability are altered

Cell homeostasis fails

Loss of controlled intracellular environment

The membrane is a functional barrier, not merely an anatomical outline.

Slide 12 · Mercury injury: Why gastrointestinal tract and kidney?

Gastrointestinal tract

A major site of contact after ingestion.

Cells are exposed during passage or absorption.

Direct protein interaction can injure the epithelium.

Kidney

Renal cells handle circulating solutes.

Excretion and concentration favor toxic exposure.

The same molecular target can exist in different organs.

Target-organ distribution follows contact, use, absorption, excretion and concentration.

Slide 13 · Cyanide inhibits the mitochondrial electron transport chain

Cyanide

Direct mitochondrial toxicant

Cytochrome oxidase inhibition

Terminal electron-transport function blocked

Oxidative phosphorylation falls

ATP synthesis is inhibited

Unlike mercury, the principal lesion here is inhibition of energy generation.

Slide 14 · Cyanide injury is an energy-failure mechanism

Respiratory chain blockade

Mitochondrial electron transfer inhibited

ATP deficiency

Energy-dependent processes compromised

Cell injury

Homeostatic failure; Severe exposure may be lethal

The molecular lesion predicts broad vulnerability of metabolically active tissues.

Slide 15 · Direct cytotoxicity is not confined to poisons

Some antineoplastic agents damage cells through direct cytotoxic effects.

Some antibiotics also have direct cell-damaging mechanisms.

Therapeutic intent does not remove the potential for cellular toxicity.

Specific organ toxicities require drug-specific evidence.

Slide 16 · Direct chemical injuries: Different first targets

Agent / class

Initial molecular interaction

Immediate consequence

Mercuric chloride

Sulfhydryl groups of membrane proteins

Permeability and ion-transport disturbance

Cyanide

Mitochondrial cytochrome oxidase

Inhibited oxidative phosphorylation

Some cytotoxic drugs

Drug-dependent cellular targets

Direct damage to sensitive cells

Slide 17 · Metabolic activation changes the toxic species

The parent chemical may be relatively inactive as a toxin.

Metabolism produces a reactive intermediate or metabolite.

The newly formed species can attack critical cell molecules.

Biotransformation can therefore produce harm rather than detoxification.

Slide 18 · The liver is a central site of xenobiotic metabolism

High metabolic

Activity

Hepatocytes express substantial drug-metabolizing enzyme activity.

Many cytochrome P450 enzymes localize in endoplasmic reticulum.

The liver can both detoxify and activate xenobiotics.

The liver’s defensive function creates a mechanism for drug-induced liver injury.

Slide 19 · The possible fates of an absorbed xenobiotic

Absorbed chemical

Entry into circulation

Tissue handling

Distribution, metabolism or storage

Disposition

Elimination, persistence or toxic effect

Toxicity cannot be inferred from absorption alone.

Slide 20 · Phase I reactions alter chemical structure

Xenobiotic

Parent compound

Phase I

Oxidation, reduction or hydrolysis

Primary metabolite

May enter phase II or be reactive

The metabolic product is not necessarily less toxic than the parent.

Slide 21 · Cytochrome P450: The major phase I catalyst

CYPs are a large family of heme-containing enzymes.

Different CYP enzymes have distinct substrate preferences.

The system catalyzes reactions involving many drugs and pollutants.

Products may be inactivated or converted to reactive toxicants.

Slide 22 · CYP enzymes occupy cellular metabolic compartments

Hepatocyte

Major site of xenobiotic processing

Endoplasmic reticulum

Principal location of hepatic CYPs

Metabolite formation

Detoxification or bioactivation

Subcellular localization is part of the causal mechanism, not simply a microscopy detail.

Slide 23 · Cytochrome P450 is expressed beyond the liver

CYP activity is prominent in hepatocytes.

The textbook also identifies skin, lung and gastrointestinal mucosa.

Extrahepatic metabolism can change local tissue exposure.

Distribution of enzymes helps explain toxic effects in particular organs.

Slide 24 · Phase II pathways increase water solubility

Chemical / phase I product

Substrate for conjugation

Phase II reaction

Glucuronidation, sulfation, methylation or GSH conjugation

Elimination

Water-soluble compounds excreted

Conjugation commonly facilitates detoxification and excretion.

Slide 25 · Phase I versus phase II metabolism

Feature

Phase I

Phase II

Representative reactions

Oxidation, reduction, hydrolysis

Glucuronidation, sulfation, methylation, GSH conjugation

Typical function

Functionalization / modification

Conjugation, often increasing water solubility

Toxicologic implication

May activate a chemical

Usually favors elimination; can remove reactive metabolites

Principal takeaway

Not always detoxifying

Important, but not an absolute safety guarantee

Slide 26 · A detoxification route

Xenobiotic

Absorbed compound

Metabolic conversion

Phase I and / or phase II

Water-soluble product

Reduced toxic potential

Excretion

Urine, bile or feces

The majority of xenobiotics are metabolized to facilitate elimination.

Slide 27 · An activation route

Xenobiotic

Parent compound

CYP-dependent reaction

Generation of a reactive species

Molecular attack

Lipids, proteins or other targets

Cell injury

Functional and structural damage

The same metabolic machinery may create a more injurious compound.

Slide 28 · Detoxification and activation can compete

Protection predominates

Conjugation or inactivation is efficient.

Reactive intermediates are neutralized.

Products become suitable for elimination.

Injury predominates

Reactive intermediate production increases.

Detoxification defenses are insufficient.

Macromolecular damage accumulates.

Toxicity depends on production versus clearance of damaging species.

Slide 29 · Why CYP activity varies among individuals

Genetic polymorphisms can affect metabolic enzyme activity.

Exposure to chemicals and drugs can induce or diminish CYP activity.

Smoking, alcohol, hormones and other agents may alter activity.

The same external exposure need not yield identical metabolic injury.

Slide 30 · CYP induction changes the amount of reactive product

Enzyme-inducing exposure

Examples include certain drugs and alcohol

CYP activity changes

Greater activity for susceptible substrates

Metabolic effect

Possible increase in bioactivation

Induction is not intrinsically toxic; Its effect depends on the substrate and pathway.

Slide 31 · Toxic metabolites commonly produce oxidative injury

Reactive metabolite

Generated by metabolic activation

Free radicals / ROS

Oxidative reactions initiated

Lipid peroxidation

Membrane lipids become damaged

Cell injury

Membrane and organelle dysfunction

Oxidant-mediated membrane injury is a major pathway in this chapter.

Slide 32 · Reactive species can affect several cell components

Membrane lipids are vulnerable to peroxidation.

Proteins can be altered by direct reactive-metabolite binding.

Oxidative stress disrupts organelle and membrane function.

Resulting injury is amplified when protective systems are overwhelmed.

Slide 33 · Lipid peroxidation damages the membrane barrier

Radical initiation

Reactive species attack membrane lipids

Lipid oxidative damage

Peroxidative reactions propagate injury

Membrane compromise

Altered barrier and organelle function

The biochemical lesion explains why cell membranes lose integrity.

Slide 34 · Membrane injury has multiple consequences

Lipid and protein damage

Structural and functional defects

Permeability changes

Abnormal ionic and molecular movement

Cellular dysfunction

Loss of homeostasis and potentially death

A damaged membrane impairs the entire cell, not just its boundary.

Slide 35 · Reactive metabolites can bind covalently to cellular molecules

Reactive chemical intermediate

Electrophilic / radical metabolite

Macromolecular binding

Covalent modification of proteins or lipids

Functional disruption

Membrane or organelle injury

Covalent binding is distinct from injury driven only by oxygen radicals.

Slide 36 · Glutathione is a chemical defense mechanism

Reactive metabolite

Potentially damaging intermediate

GSH conjugation

Neutralization of reactive species

Less reactive product

Allows detoxification and removal

Adequate glutathione availability is protective in acetaminophen metabolism.

Slide 37 · Injury develops when defenses are outpaced

Sufficient defense

Reactive species are neutralized.

Covalent injury remains limited.

Cell may maintain or restore homeostasis.

Insufficient defense

Reactive species persist.

Protein and membrane damage accumulates.

Cell injury can become irreversible.

This schematic contrast explains the threshold behavior of many toxic exposures.

Slide 38 · Mitochondria link chemical injury to energy failure

Mitochondrial target

Respiratory chain or mitochondrial membranes

Impaired function

Reduced ATP generation

Energy-dependent failure

Progressive cell dysfunction

Cyanide acts directly; Reactive metabolites may damage mitochondria secondarily.

Slide 39 · ATP depletion produces characteristic cell dysfunction

Less ATP available

Deficient oxidative phosphorylation

Ion pumps fail

Disordered Na⁺ and water movement

Cell swelling

Reversible injury initially possible

Prolonged damage

Necrosis may follow

The severe end of ATP depletion converges with general mechanisms of cell injury.

Slide 40 · Chemical injury may be reversible or lethal

Reversible injury

Cell function is impaired.

Homeostasis and membranes may recover.

Swelling can precede irreversible changes.

Irreversible injury

Membrane and mitochondrial damage progresses.

Necrosis may follow severe or sustained insult.

Cell death is not a synonym for every toxic exposure.

Do not diagnose necrosis from exposure alone.

Slide 41 · Carbon tetrachloride exemplifies metabolic activation

CCl₄ was formerly used in the dry-cleaning industry.

Its important toxic product is generated through CYP metabolism.

The reactive product is the trichloromethyl radical (•CCl₃).

The radical causes lipid peroxidation and cell injury.

Slide 42 · Carbon tetrachloride: The activating reaction

Carbon tetrachloride

CCl₄ parent chemical

Cytochrome P450

Metabolic activation

Trichloromethyl radical

•CCl₃ reactive species

The product of biotransformation, rather than CCl₄ alone, drives the classic injury pathway.

Slide 43 · Carbon tetrachloride: Injury cascade

•CCl₃ formed

Free-radical intermediate

Lipid peroxidation

Membranes oxidatively damaged

Organelle dysfunction

Multiple structures affected

Cell injury

Loss of normal cellular function

This example links xenobiotic metabolism directly to radical-mediated membrane damage.

Slide 44 · Carbon tetrachloride: Interpretive checkpoints

Observation

Mechanistic interpretation

Parent compound present

Exposure has occurred; exposure alone does not specify severity

CYP activity in target cells

Reactive metabolite can be generated

Trichloromethyl radical detected conceptually

Radical initiates oxidative injury

Membrane lipid peroxidation

Functional and structural membrane damage

Slide 45 · Acetaminophen illustrates a dose-sensitive metabolic balance

At usual doses, most acetaminophen undergoes conjugation.

A smaller fraction is bioactivated to a reactive product.

Glutathione normally neutralizes that product.

Excess exposure can overwhelm this protective pathway.

Slide 46 · Most acetaminophen is safely conjugated

Acetaminophen

Therapeutic exposure

Phase II metabolism

Glucuronide and sulfate conjugation

Urinary elimination

Conjugated products excreted

Conjugation is the main metabolic route under usual conditions.

Slide 47 · A minority of acetaminophen forms NAPQI

Acetaminophen

Minor metabolic fraction

CYP enzymes

Mainly CYP2E

NAPQI

Highly reactive metabolite

NAPQI = N-acetyl-p-benzoquinoneimine.

Slide 48 · Glutathione normally neutralizes NAPQI

NAPQI

Reactive metabolite

GSH conjugation

Normally inactivates NAPQI

Detoxified product

Lower reactivity, favoring elimination

The protective pathway is dependent on available glutathione.

Slide 49 · Excess acetaminophen shifts metabolism toward injury

Large acetaminophen load

Detoxification capacity challenged

NAPQI accumulates

Available GSH becomes insufficient

Hepatocyte injury

Membranes and mitochondria damaged

Overdose toxicity reflects imbalance between reactive metabolite formation and detoxification.

Slide 50 · NAPQI causes injury through two reinforcing pathways

Protein adduct formation

Reactive NAPQI binds covalently to hepatic proteins.

Membrane and mitochondrial functions are disrupted.

This is a direct effect of the metabolite.

Glutathione depletion

Consumption of GSH reduces antioxidant defense.

Hepatocytes become susceptible to ROS.

Oxidative damage magnifies the primary injury.

Both mechanisms contribute to hepatocellular damage.

Slide 51 · Acetaminophen toxicity: Centrilobular hepatic necrosis

Centrilobular necrosis means injury near the central vein.

Central vein

Zone 3

(centrilobular)

Periportal regions

Schematic only: Not histology, not drawn to anatomical scale.

Slide 52 · Acetaminophen poisoning: Clinicopathologic sequence

Toxic exposure

Large dose or increased susceptibility

Hepatocyte necrosis

Centrilobular pattern

Hepatic dysfunction

May progress to jaundice and liver failure

The morphologic pattern is a consequence of the biochemical toxicant pathway.

Slide 53 · N-acetylcysteine acts on the toxic mechanism

Acetaminophen overdose

Risk of NAPQI accumulation

N-acetylcysteine

Replenishes glutathione

Improved NAPQI detoxification

Helps limit hepatocyte injury

Early treatment; This is mechanistic teaching, not a treatment protocol.

Slide 54 · Acetaminophen toxicity may extend beyond hepatocytes

Liver injury is the dominant clinicopathologic concern.

Some poisoned patients also have concurrent kidney injury.

The extent of tissue damage depends on exposure and defense mechanisms.

Molecular pathway and injured organ must both be considered.

Slide 55 · Carbon tetrachloride versus acetaminophen

Feature

Carbon tetrachloride

Acetaminophen

Parent compound

Industrial chemical

Analgesic drug

Toxic product

Trichloromethyl radical (•CCl₃)

NAPQI

Key activation pathway

CYP-dependent radical formation

Minor CYP-dependent pathway

Primary emphasis

Lipid peroxidation

Protein adducts + GSH depletion

Organ relevance

Liver metabolic activation

Centrilobular hepatocellular necrosis

Slide 56 · Toxic mechanism predicts the initial cellular defect

Initial insult

Immediate molecular defect

Downstream injury

Mercury

Protein sulfhydryl group binding

Membrane permeability / ion transport

Cyanide

Cytochrome oxidase blockade

ATP depletion

CCl₄ metabolite

Free-radical formation

Lipid peroxidation

Acetaminophen metabolite

Protein adducts; depleted GSH

Mitochondrial and oxidant injury

Slide 57 · Structural patterns are downstream of molecular injury

Potentially reversible changes

ATP reduction may disturb ion transport.

Intracellular sodium and water can accumulate.

Swelling reflects impaired cell homeostasis.

Necrotic injury

Severe injury disrupts membranes and organelles.

Loss of cell integrity reflects irreversibility.

Acetaminophen can produce centrilobular necrosis.

The microscopic endpoint depends on insult severity and duration.

Slide 58 · What a schematic cannot establish

A mechanism diagram demonstrates an established causal sequence.

It does not show actual histologic tissue damage in a patient.

A specific morphologic diagnosis requires genuine microscopic evidence.

The centrilobular drawing in this lecture is an anatomical teaching aid.

Slide 59 · A practical toxic-injury reasoning framework

Identify exposure

Agent and route

Determine first lesion

Direct binding or metabolic activation

Predict cell target

Membrane, enzyme or organelle

Interpret injury

Tissue and morphologic consequences

Follow the causal chain before memorizing the named toxin.

Slide 60 · Case application: Mercury

A patient is exposed to mercuric chloride. Toxic injury develops in gastrointestinal and renal tissues. The mechanism includes impaired ion transport and increased membrane permeability.

Which cellular target explains these effects?

Slide 61 · Mercury case: Causal explanation

Mercuric chloride

Exposure

Protein –SH binding

Direct molecular interaction

Membrane defects

Permeability and ion transport change

The primary mechanism is direct toxicity, not obligatory CYP bioactivation.

Slide 62 · Case application: Cyanide

A toxic exposure rapidly interferes with mitochondrial oxidative phosphorylation. The affected process is downstream of direct inhibition of cytochrome oxidase.

Why does a respiratory enzyme lesion compromise the whole cell?

Slide 63 · Cyanide case: Causal explanation

Cytochrome oxidase

Directly inhibited

Oxidative phosphorylation

Falls as electron transport is impaired

ATP production

Declines, compromising energy-dependent function

The central lesion is loss of bioenergetic capacity.

Slide 64 · Case application: Acetaminophen

After an excessive acetaminophen exposure, a patient develops hepatic injury. The toxic product is generated by CYP-mediated metabolism, and glutathione buffering becomes insufficient.

Identify the reactive metabolite and its two key injury mechanisms.

Slide 65 · Acetaminophen case: Causal explanation

Toxic metabolite

The toxic intermediate is NAPQI.

Formed through a minor CYP pathway.

Accumulates when detoxification is exceeded.

Cellular mechanisms

Covalent protein binding injures cell structures.

GSH depletion increases vulnerability to ROS.

Centrilobular necrosis can ensue.

This is metabolic activation with failure of a protective conjugation pathway.

Slide 66 · Four toxins: A single mechanistic comparison

Toxicant

Direct target / active product

Dominant pathology mechanism

Mercuric chloride

Protein sulfhydryl groups

Membrane dysfunction

Cyanide

Cytochrome oxidase

Energy failure

Carbon tetrachloride

Trichloromethyl radical

Lipid peroxidation

Acetaminophen

NAPQI

Protein binding and GSH depletion

Slide 67 · Five principles that organize toxic injury

Identify whether the parent compound or a metabolite causes injury.

Locate the affected molecular target before predicting morphology.

Recognize that CYP enzymes can detoxify or bioactivate chemicals.

Balance reactive-product formation against glutathione and clearance.

Connect the cellular defect to tissue susceptibility and cell death.

Slide 68 · Core reading and source limits

Robbins, Cotran & Kumar: Pathologic Basis of Disease — Chemical (Toxic) Injury.

The same textbook: Environmental and Nutritional Diseases — toxicant metabolism.

The same textbook: acetaminophen metabolism and hepatotoxicity.

Mechanistic drawings are original schematics; no textbook micrographs are reproduced.